Canada markets closed

Agile Therapeutics, Inc. (AGRX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.40000.0000 (0.00%)
At close: 02:59PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-14,465
-14,465
-25,412
-71,067
-51,853
Depreciation & amortization
386
386
1,534
2,223
276
Stock based compensation
1,981
1,981
2,493
3,338
2,818
Change in working capital
7,417
7,417
-2,530
-2,853
107
Accounts receivable
-15
-15
-1,844
-668
-865
Inventory
-2,207
-2,207
-763
-6,289
0
Other working capital
-9,577
-9,577
-36,080
-65,471
-47,664
Other non-cash items
1,063
1,063
1,969
1,661
1,341
Net cash provided by operating activites
-9,577
-9,577
-35,947
-65,202
-47,311
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-133
-269
-353
Purchases of investments
-
-
0
0
-54,837
Sales/Maturities of investments
0
0
0
39,729
14,500
Net cash used for investing activites
0
0
-133
39,460
-40,690
Cash flows from financing activities
Debt repayment
-1,347
-1,347
-17,375
0
0
Common stock issued
8,235
8,235
35,430
30,347
48,434
Other financing activites
-
-
-
-
-1,059
Net cash used privided by (used for) financing activities
6,888
6,888
22,183
30,422
67,985
Net change in cash
-2,689
-2,689
-13,897
4,680
-20,016
Cash at beginning of period
5,246
5,246
19,143
14,463
34,479
Cash at end of period
2,557
2,557
5,246
19,143
14,463
Free Cash Flow
Operating Cash Flow
-9,577
-9,577
-35,947
-65,202
-47,311
Capital Expenditure
-
-
-133
-269
-353
Free Cash Flow
-9,577
-9,577
-36,080
-65,471
-47,664